REGULATED IMPORT PATHWAYS

Imported medicinal cannabis products are subject to strict regulatory controls.

This includes approvals, licensing, and compliance with Australian standards to ensure appropriate oversight within medical access pathways.

Importation does not change how patients access medicinal cannabis, which remains dependent on clinical assessment.

SUPPLY AND DISTRIBUTION

Imported products may form part of the broader medicinal cannabis supply chain.

This can involve:

• licensed importers

• regulated distributors

• pharmacies

• prescribing practitioners

Patients can learn more about medicinal cannabis prescriptions in Australia to understand how supply and prescribing are managed within a regulated framework.

CLINICAL ACCESS REMAINS THE SAME

Regardless of origin, medicinal cannabis is not available for direct purchase by the public.

Access requires a consultation with a qualified practitioner, who will assess individual circumstances and determine whether this approach may be appropriate.

Understanding the consultation process can help explain how access is managed.

QUALITY AND COMPLIANCE

Imported medicinal cannabis products must meet Australian regulatory requirements relating to quality, handling, and distribution.

These requirements are designed to ensure that products supplied through medical pathways meet appropriate standards.

IMPORTANT INFORMATION

Medicinal cannabis is not suitable for all patients.

Access is subject to clinical assessment and regulatory requirements.

This website provides general information only and does not constitute medical advice.

SPEAK WITH A QUALIFIED PRACTITIONER

If you would like to understand whether this pathway may be appropriate, the next step is to speak with a qualified practitioner.